NeuroOne Medical Technologies Corporation Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
NeuroOne Medical Technologies Corporation (NMTC) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$4.52 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-13
- NeuroOne Medical Technologies Corporation cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-12-31 was -$3.01M.
- NeuroOne Medical Technologies Corporation cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-12-31 was -$325.69K.
- NeuroOne Medical Technologies Corporation cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-12-31 was -$2.64M.
- NeuroOne Medical Technologies Corporation cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2022-12-31 was -$3.49M, a 137.63% decline year-over-year.
- NeuroOne Medical Technologies Corporation cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was $5.11M.
- NeuroOne Medical Technologies Corporation cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$3.86M.
- NeuroOne Medical Technologies Corporation cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$2.84M, a 325.41% decline from fiscal 2022.
- NeuroOne Medical Technologies Corporation cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was $1.26M, a 56.06% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$4.52M 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | -$3.77M 10-Q/A · filed 2026-06-12 | |||
| 2025-12-31 | -$3.01M 10-Q · filed 2026-02-17 | |||
| 2025-09-30 | $5.11M 10-K · filed 2025-12-17 | |||
| 2025-06-30 | $6.58M 10-Q · filed 2026-08-13 | |||
| 2025-03-31 | -$139.79K 10-Q/A · filed 2026-06-12 | |||
| 2024-12-31 | -$325.69K 10-Q · filed 2026-02-17 | |||
| 2024-09-30 | -$3.86M 10-K · filed 2025-12-17 | |||
| 2024-06-30 | -$3.70M 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | -$2.89M 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | -$2.64M 10-Q · filed 2025-02-12 | |||
| 2023-09-30 | -$2.84M 10-K · filed 2024-12-17 | |||
| 2023-06-30 | -$5.08M 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | -$4.56M 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | -$3.49M 10-Q · filed 2024-02-13 | |||
| 2022-09-30 | $1.26M 10-K · filed 2023-12-15 | |||
| 2022-06-30 | $3.28M 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | $5.97M 10-Q · filed 2023-05-12 | |||
| 2021-12-31 | $9.28M 10-Q · filed 2023-02-13 | |||
| 2021-09-30 | $2.86M 10-K · filed 2022-12-22 | |||
| 2021-06-30 | $4.95M 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | $7.24M 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $3.09M 10-Q · filed 2022-02-14 | |||
| 2020-09-30 | $3.78M 10-K · filed 2021-12-15 | |||
| 2020-06-30 | $3.56M 10-Q · filed 2021-08-13 | |||
| 2020-03-31 | $486.50K 10-Q · filed 2021-05-14 | |||
| 2019-12-31 | $1.78M 10-Q · filed 2021-02-16 | |||
| 2019-09-30 | $247.49K 10-K · filed 2020-12-09 | |||
| 2019-06-30 | $1.23M 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |